Table 1 Baseline characteristics
Variables | Number of patients (%) |
|---|---|
Age (years) | |
Median (IQR) | 65 (61 to 68) |
Sex | |
Female | 9 (69 %) |
Male | 4 (31 %) |
Primary site | |
Gall bladder | 3 (23 %) |
Bile duct | 9 (69 %) |
Ampulla | 1 (8 %) |
ECOG PS | |
0 | 9 (69 %) |
1 | 4 (31 %) |
T-stage | |
T1 | 1 (8 %) |
T2 | 0 (0 %) |
T3 | 8 (62 %) |
T4 | 1 (8 %) |
TX | 3 (23 %) |
N-stage | |
N0 | 2 (15 %) |
N1 | 5 (38 %) |
N2 | 1 (8 %) |
NX | 5 (38 %) |
M-stage | |
M0 | 1 (8 %) |
M1a | 10 (77 %) |
MX | 2 (15 %) |
Tumour differentiation | |
Well/Moderately differentiated | 6 (46 %) |
Poorly differentiated | 6 (46 %) |
Not specified | 1 (8 %) |
Previous treatment | |
None | 5 (38 %) |
Chemotherapy | 0 (0 %) |
Surgery | 8 (62 %) |
Radiotherapy | 0 (0 %) |
Other | 0 (0 %) |
2+ types | 0 (0 %) |
Biliary Stent Insertions | 7 (54 %) |